Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Vaccination | Research article

Observational study of a new strategy and management policy for measles prevention in medical personnel in a hospital setting

Authors: Chang-Pan Liu, Hsi-Peng Lu, Tainyi Luor

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

At the end of March 2018, a clustered outbreak of measles associated with health care workers occurred in northern Taiwan. Prior to this study, the policy for measles vaccination for physicians and nurses in MacKay Memorial Hospital, Taiwan was encouragement of vaccination in medical personnel working in the emergency room or other high risk divisions without prior testing for measles antibody, and vaccination coverage was only 85.3%. It was important to urgently formulate a new strategy to achieve zero tolerance for intra-hospital transmission and epidemic prevention. This study aimed to explore the effectiveness of a new strategy for the prevention of an outbreak of measles.

Methods

This study was conducted from April 23, 2018 to May 22, 2018 in the MacKay Memorial Hospital, a medical center and tertiary teaching hospital with 2200 beds in northern Taiwan. First-line medical personnel in the hospital underwent a free screening for measles antibody as a new strategy for measles outbreak prevention. Susceptible medical personnel were advised to receive measles vaccination.

Results

A total of 719 first-line medical personnel were enrolled for the general survey. Measles seropositivity was 76.1% (287/377) in the generation born after 1978 (vaccinated), and 96.5% (330/342) in the generation born before 1978 (p < 0.001), while the overall seropositivity was 85.8% (617/719). Vaccination coverage of susceptible personnel under the new strategy reached 86.3% in the first month (88/102) following the survey. At the end of the first month after implementation of the new strategy, 98.1% of the medical personnel were seropositive or revaccinated, and reached 99.4% at the end of the second month.

Conclusions

In this study, rapid, free antibody screening during a measles outbreak and subsequent vaccination of those susceptible resulted in most of the first-line medical personnel being seropositive or revaccinated. The new strategy was effective, time saving, used little manpower, and of low cost. Screening for measles antibody free of charge followed by vaccination of seronegative medical personnel can be regarded as an effective health management strategy to reduce and prevent the spread of measles infection.
Literature
1.
go back to reference Torner N, Anton A, Barrabeig I, Lafuente S, Parron I, Arias C, et al. Epidemiology of two large measles virus outbreaks in Catalonia: what a difference the month of administration of the first dose of vaccine makes. Hum Vaccin Immunother. 2013;9(3):675–80.CrossRef Torner N, Anton A, Barrabeig I, Lafuente S, Parron I, Arias C, et al. Epidemiology of two large measles virus outbreaks in Catalonia: what a difference the month of administration of the first dose of vaccine makes. Hum Vaccin Immunother. 2013;9(3):675–80.CrossRef
2.
go back to reference Nsubuga F, Bulage L, Ampeire I, Matovu JKB, Kasasa S, Tanifum P, et al. Factors contributing to measles transmission during an outbreak in Kamwenge District, Western Uganda, April to august 2015. BMC Infect Dis. 2018;18(1):21.CrossRef Nsubuga F, Bulage L, Ampeire I, Matovu JKB, Kasasa S, Tanifum P, et al. Factors contributing to measles transmission during an outbreak in Kamwenge District, Western Uganda, April to august 2015. BMC Infect Dis. 2018;18(1):21.CrossRef
3.
go back to reference Tang X, Geater A, McNeil E, Deng Q, Dong A, Zhong G. Spatial, temporal and spatio-temporal clusters of measles incidence at the county level in Guangxi, China during 2004-2014: flexibly shaped scan statistics. BMC Infect Dis. 2017;17(1):243.CrossRef Tang X, Geater A, McNeil E, Deng Q, Dong A, Zhong G. Spatial, temporal and spatio-temporal clusters of measles incidence at the county level in Guangxi, China during 2004-2014: flexibly shaped scan statistics. BMC Infect Dis. 2017;17(1):243.CrossRef
4.
go back to reference Getahun M, Beyene B, Ademe A, Teshome B, Tefera M, Afework A, et al. Epidemiology of laboratory confirmed measles virus cases in the southern nations of Ethiopia, 2007-2014. BMC Infect Dis. 2017;17(1):87.CrossRef Getahun M, Beyene B, Ademe A, Teshome B, Tefera M, Afework A, et al. Epidemiology of laboratory confirmed measles virus cases in the southern nations of Ethiopia, 2007-2014. BMC Infect Dis. 2017;17(1):87.CrossRef
5.
go back to reference Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004;189(Suppl 1):S4–16.PubMed Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004;189(Suppl 1):S4–16.PubMed
6.
go back to reference Mafigiri R, Nsubuga F, Ario AR. Risk factors for measles death: Kyegegwa District, western Uganda, February-September, 2015. BMC Infect Dis. 2017;17(1):462.CrossRef Mafigiri R, Nsubuga F, Ario AR. Risk factors for measles death: Kyegegwa District, western Uganda, February-September, 2015. BMC Infect Dis. 2017;17(1):462.CrossRef
7.
go back to reference Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, et al. The basic reproduction number (R 0) of measles: a systematic review. Lancet Infect Dis. 2017;17(12):e420–e8.CrossRef Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, et al. The basic reproduction number (R 0) of measles: a systematic review. Lancet Infect Dis. 2017;17(12):e420–e8.CrossRef
8.
go back to reference van Boven M, Kretzschmar M, Wallinga J, O'Neill PD, Wichmann O, Hahne S. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface. 2010;7(52):1537–44.CrossRef van Boven M, Kretzschmar M, Wallinga J, O'Neill PD, Wichmann O, Hahne S. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface. 2010;7(52):1537–44.CrossRef
9.
go back to reference Dominguez A, Torner N, Barrabeig I, Rovira A, Rius C, Cayla J, et al. Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule. Clin Infect Dis. 2008;47(9):1143–9.CrossRef Dominguez A, Torner N, Barrabeig I, Rovira A, Rius C, Cayla J, et al. Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule. Clin Infect Dis. 2008;47(9):1143–9.CrossRef
11.
go back to reference Lievano F, Galea SA, Thornton M, Wiedmann RT, Manoff SB, Tran TN, et al. Measles, mumps, and rubella virus vaccine (M-M-R II): a review of 32 years of clinical and postmarketing experience. Vaccine. 2012;30(48):6918–26.CrossRef Lievano F, Galea SA, Thornton M, Wiedmann RT, Manoff SB, Tran TN, et al. Measles, mumps, and rubella virus vaccine (M-M-R II): a review of 32 years of clinical and postmarketing experience. Vaccine. 2012;30(48):6918–26.CrossRef
13.
go back to reference Fiebelkorn AP, Seward JF, Orenstein WA. A global perspective of vaccination of healthcare personnel against measles: systematic review. Vaccine. 2014;32(38):4823–39.CrossRef Fiebelkorn AP, Seward JF, Orenstein WA. A global perspective of vaccination of healthcare personnel against measles: systematic review. Vaccine. 2014;32(38):4823–39.CrossRef
14.
go back to reference McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. CDC. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2013;62(RR-04):1–34.PubMed McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. CDC. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2013;62(RR-04):1–34.PubMed
15.
go back to reference Jia H, Ma C, Lu M, Fu J, Rodewald LE, Su Q, et al. Transmission of measles among healthcare workers in hospital W, Xinjiang autonomous region, China, 2016. BMC Infect Dis. 2018;18(1):36.CrossRef Jia H, Ma C, Lu M, Fu J, Rodewald LE, Su Q, et al. Transmission of measles among healthcare workers in hospital W, Xinjiang autonomous region, China, 2016. BMC Infect Dis. 2018;18(1):36.CrossRef
16.
go back to reference WHO. World Health. Organization: measles vaccines: WHO position paper-April 2017. Wkly Epidemiol Rec. 2017;92:205–28. WHO. World Health. Organization: measles vaccines: WHO position paper-April 2017. Wkly Epidemiol Rec. 2017;92:205–28.
19.
go back to reference Rogers E. M. Diffusion of innovation. 5th ed. New York: Free Press; 2003. Rogers E. M. Diffusion of innovation. 5th ed. New York: Free Press; 2003.
20.
go back to reference WHO/Europe. World Health Organization regional Office for Europe: measles cases hit record high in the European region. http://www.euro.who.int/en/media-centre/sections/press-releases/2018/measles-cases-hit-record-high-in-the-european-region (2018). Accessed 22 May 2018. WHO/Europe. World Health Organization regional Office for Europe: measles cases hit record high in the European region. http://​www.​euro.​who.​int/​en/​media-centre/​sections/​press-releases/​2018/​measles-cases-hit-record-high-in-the-european-region (2018). Accessed 22 May 2018.
21.
go back to reference Chen CJ, Lee PI, Hsieh YC, Chen PY, Ho YH, Chang CJ, et al. Waning population immunity to measles in Taiwan. Vaccine. 2012;30(47):6721–7.CrossRef Chen CJ, Lee PI, Hsieh YC, Chen PY, Ho YH, Chang CJ, et al. Waning population immunity to measles in Taiwan. Vaccine. 2012;30(47):6721–7.CrossRef
22.
go back to reference Liu DP, Wang ET, Pan YH, Cheng SH. Innovative applications of immunisation registration information systems: example of improved measles control in Taiwan. Euro Surveill. 2014;19(50):20994.CrossRef Liu DP, Wang ET, Pan YH, Cheng SH. Innovative applications of immunisation registration information systems: example of improved measles control in Taiwan. Euro Surveill. 2014;19(50):20994.CrossRef
23.
go back to reference Hall R, Jolley D. International measles incidence and immunization coverage. J Infect Dis. 2011;204(Suppl 1):S158–63.CrossRef Hall R, Jolley D. International measles incidence and immunization coverage. J Infect Dis. 2011;204(Suppl 1):S158–63.CrossRef
24.
go back to reference Griffin DE. The immune response in measles: virus control, clearance and protective immunity. Viruses. 2016;8(10):282.CrossRef Griffin DE. The immune response in measles: virus control, clearance and protective immunity. Viruses. 2016;8(10):282.CrossRef
25.
go back to reference Kinoshita R, Nishiura H. Assessing age-dependent susceptibility to measles in Japan. Vaccine. 2017;35(25):3309–17.CrossRef Kinoshita R, Nishiura H. Assessing age-dependent susceptibility to measles in Japan. Vaccine. 2017;35(25):3309–17.CrossRef
26.
go back to reference Ho TS, Wang SM, Wang LR, Liu CC. Changes in measles seroepidemiology of healthcare workers in southern Taiwan. Epidemiol Infect. 2012;140(3):426–31.CrossRef Ho TS, Wang SM, Wang LR, Liu CC. Changes in measles seroepidemiology of healthcare workers in southern Taiwan. Epidemiol Infect. 2012;140(3):426–31.CrossRef
27.
go back to reference Hassen MN, Woyessa AB, Getahun M, Beyene B, Buluanger L, Ademe A, et al. Epidemiology of measles in the metropolitan setting, Addis Ababa, Ethiopia, 2005-2014: a retrospective descriptive surveillance data analysis. BMC Infect Dis. 2018;18(1):400.CrossRef Hassen MN, Woyessa AB, Getahun M, Beyene B, Buluanger L, Ademe A, et al. Epidemiology of measles in the metropolitan setting, Addis Ababa, Ethiopia, 2005-2014: a retrospective descriptive surveillance data analysis. BMC Infect Dis. 2018;18(1):400.CrossRef
28.
go back to reference Poland GA, Jacobson RM. The re-emergence of measles in developed countries: time to develop the next-generation measles vaccines? Vaccine. 2012;30(2):103–4.CrossRef Poland GA, Jacobson RM. The re-emergence of measles in developed countries: time to develop the next-generation measles vaccines? Vaccine. 2012;30(2):103–4.CrossRef
Metadata
Title
Observational study of a new strategy and management policy for measles prevention in medical personnel in a hospital setting
Authors
Chang-Pan Liu
Hsi-Peng Lu
Tainyi Luor
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Vaccination
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4139-4

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue